Most SOD1 mutations are pathogenic, and their identification can lead to early access to treatment
Most SOD1 mutations are pathogenic, and their identification can lead to early access to treatment
About this item
Full title
Most SOD1 mutations are pathogenic, and their identification can lead to early access to treatment
Author / Creator
Publisher
England: BMJ Publishing Group Ltd
Journal title
Journal of neurology, neurosurgery and psychiatry, 2024-12, Vol.95 (12), p.1219-1220
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Alternative Titles
Full title
Most SOD1 mutations are pathogenic, and their identification can lead to early access to treatment
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3072763268
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3072763268
Other Identifiers
ISSN
0022-3050,1468-330X
E-ISSN
1468-330X
DOI
10.1136/jnnp-2024-333939
